VANDERBILT UNIVERSITY MEDICAL CENTER IMAGE: WESLEY SELF, MD, MPH, ASSOCIATE PROFESSOR OF EMERGENCY MEDICINE, VICE PRESIDENT FOR CLINICAL RESEARCH NETWORKS AND STRATEGY AT VUMC AND LEAD AUTHOR OF THE STUDY. CREDIT: VANDERBILT UNIVERSITY MEDICAL CENTER Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to...
Researchers found that convalescent plasma reduced the need for hospitalization by half for outpatients who participated in the study. Convalescent plasma is plasma from people who have recovered from COVID-19 and whose blood contains antibodies against SARS-CoV-2, the virus that causes COVID-19. CONVALESCENT PLASMA IS THE ONLY ANTIBODY THERAPY THAT “KEEPS UP WITH SARS-COV-2 VARIANTS,”...
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO SAN ANTONIO (June 17, 2021) — Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. The findings by the COVID-19 and Cancer Consortium (CCC19) are newly published in the peer-reviewed journal JAMA Oncology. The Mays Cancer Center, home...
RICHARD HARRIS March 10, 2021 5:01 AM Melissa Cruz elevated her arm after donating COVID-19 convalescent plasma in April 2020, as phlebotomist Jenee Wilson shut down the collection equipment at Bloodworks Northwest in Seattle.Karen Ducey/Getty Images More than half a million Americans have received an experimental treatment for COVID-19 called convalescent plasma. But a year...
